Zio XT for detecting cardiac arrhythmias

Zio XT (iRhythm Technologies) is an ambulatory heart monitoring service, designed to detect cardiac arrythmias in people with infrequent symptoms (every 24 hours or longer). It is comprised of the Zio Patch and the Zio Report. The Zio Patch is a self-adhesive, wireless ECG, that is applied to the left upper chest and worn continuously for 2 weeks. The wearer can go about their normal daily activities during monitoring, including showering or bathing because the device is water resistant. After the monitoring period, the Zio Patch is removed and sent to the company via prepaid post. The company analyses the ECG recordings using machine-learned algorithms and distils the results into the Zio Report which is sent electronically to the patient’s clinician.

The update is suspended due to a delay with the manufacturer's submission, caused by the delay in the reporting of trial data. The evaluation will resume development in due course. Stakeholders will be updated when new dates are scheduled

Status:

Suspended

Technology type:

Device

Decision:

Selected

Reason for decision:

Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources

Further information:

This will be an update to the existing Guidance (MTG52).

Process:

MTG

ID number:

591

Project Team

Project lead

Farhaan Jamadar

Email enquiries

If you have any queries please email [email protected]

Stakeholders

External assessment group

The Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH)

Manufacturers

iRhythm Technologies, Inc.

External Assessment Group:

The Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH)

Timeline

Key events during the development of the guidance:

For further information on our processes and methods, please see our CHTE processes and methods manual